Paper40150879
Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions.
Rafik ST and 3 others. FEBS Open Bio, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions. Papers, record 40150879. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40150879
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bioengineering facets of the tumor microenvironment in 3D tumor models: insights into cellular, biophysical and biochemical interactions.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Tumor Microenvironment | Major topic |
| Neoplasms | Major topic |
| Bioengineering | Major topic |
| Humans | |
| Tissue Engineering | |
| Models, Biological | |
| Animals |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Egyptian Ministry of Higher Education & Scientific Research | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37518181 | Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets. | Signal Transduct Target Ther | 2023 | https://conductscience.org/library/papers/37518181 | PubMed |
| 2 | 35657027 | Recapitulated Crosstalk between Cerebral Metastatic Lung Cancer Cells and Brain Perivascular Tumor Microenvironment in a Microfluidic Co-Culture Chip. | Adv Sci (Weinh) | 2022 | https://conductscience.org/library/papers/35657027 | PubMed |
| 3 | 17545839 | Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) pathway signaling. | J Thorac Oncol | 2007 | https://conductscience.org/library/papers/17545839 | PubMed |
| 4 | 27820599 | Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression. | Nat Cell Biol | 2016 | https://conductscience.org/library/papers/27820599 | PubMed |
| 5 | 36333907 | Evaluating the Impact of a Biomimetic Mechanical Environment on Cancer Invasion and Matrix Remodeling. | Adv Healthc Mater | 2023 | https://conductscience.org/library/papers/36333907 | PubMed |
| 6 | 34885111 | Stromal Cells Promote Matrix Deposition, Remodelling and an Immunosuppressive Tumour Microenvironment in a 3D Model of Colon Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34885111 | PubMed |
| 7 | 37130516 | Reconstruction of tumor microenvironment viain vitrothree-dimensional models. | Biofabrication | 2023 | https://conductscience.org/library/papers/37130516 | PubMed |
| 8 | 21466972 | Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. | Drug Resist Updat | 2011 | https://conductscience.org/library/papers/21466972 | PubMed |
| 9 | 20870407 | Forcing form and function: biomechanical regulation of tumor evolution. | Trends Cell Biol | 2011 | https://conductscience.org/library/papers/20870407 | PubMed |
| 10 | 30002710 | 2D and 3D cell cultures - a comparison of different types of cancer cell cultures. | Arch Med Sci | 2018 | https://conductscience.org/library/papers/30002710 | PubMed |
| 11 | 28920514 | Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases. | J Cereb Blood Flow Metab | 2018 | https://conductscience.org/library/papers/28920514 | PubMed |
| 12 | 38679256 | Dual-crosslinking gelatin-hyaluronic acid methacrylate based biomimetic PDAC desmoplastic niche enhances tumor-associated macrophages recruitment and M2-like polarization. | Int J Biol Macromol | 2024 | https://conductscience.org/library/papers/38679256 | PubMed |
| 13 | 32273760 | HIF-1α, TWIST-1 and ITGB-1, associated with Tumor Stiffness, as Novel Predictive Markers for the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32273760 | PubMed |
| 14 | 27228477 | Characterization of Cell-Type-Specific Drug Transport and Resistance of Breast Cancers Using Tumor-Microenvironment-on-Chip. | Mol Pharm | 2016 | https://conductscience.org/library/papers/27228477 | PubMed |
| 15 | 22440008 | Discovery of small molecule cancer drugs: successes, challenges and opportunities. | Mol Oncol | 2012 | https://conductscience.org/library/papers/22440008 | PubMed |
| 16 | 38883829 | Patient-specific colorectal-cancer-associated fibroblasts modulate tumor microenvironment mechanics. | iScience | 2024 | https://conductscience.org/library/papers/38883829 | PubMed |
| 17 | 11025665 | Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. | Nat Cell Biol | 2000 | https://conductscience.org/library/papers/11025665 | PubMed |
| 18 | 34761350 | 3D modeling in cancer studies. | Hum Cell | 2022 | https://conductscience.org/library/papers/34761350 | PubMed |
| 19 | 21376230 | Hallmarks of cancer: the next generation. | Cell | 2011 | https://conductscience.org/library/papers/21376230 | PubMed |
| 20 | 39461060 | Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression. | Biomaterials | 2025 | https://conductscience.org/library/papers/39461060 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909412 | Reconstructing the Tumor Mechanical Microenvironment in Organoids: From Mechanical Cues to Biomimetic Modeling and Therapeutic Insights. | Int J Med Sci | 2026 | https://conductscience.org/library/papers/42909412 | PubMed |
| 42211735 | The role of the tumor microenvironment in mediating radiopharmaceutical therapy: bridging nuclear medicine and cancer immunotherapy. | Mil Med Res | 2026 | https://conductscience.org/library/papers/42211735 | PubMed |
| 41599141 | Breaking Barriers: Immune Checkpoint Inhibitors in Breast Cancer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41599141 | PubMed |
| 41537745 | Unlocking the Therapeutic Potential of Integrin-Linked Kinase Inhibitors in Bioengineered 3D Breast Tumor Stroma Models. | FASEB J | 2026 | https://conductscience.org/library/papers/41537745 | PubMed |
| 41489992 | A step further in our commitment to support early career researchers (ECRs). | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/41489992 | PubMed |
| 41440181 | High-Throughput 3D Bioprinted Organoids of Skin Cancer Utilized for Diagnosis and Personalized Therapy. | Curr Oncol | 2025 | https://conductscience.org/library/papers/41440181 | PubMed |
| 41031605 | Decoding tumor-stroma interactions: from molecular crosstalk to therapeutic targets. | FEBS Open Bio | 2025 | https://conductscience.org/library/papers/41031605 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40150879
GET https://conductscience.org/api/papers/v1/40150879/references?page=2